Dynavax Technologies (DVAX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to -$647.8 million.
- Dynavax Technologies' Enterprise Value rose 1520.66% to -$647.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$647.8 million, marking a year-over-year increase of 1520.66%. This contributed to the annual value of -$713.8 million for FY2024, which is 383.51% up from last year.
- Latest data reveals that Dynavax Technologies reported Enterprise Value of -$647.8 million as of Q3 2025, which was up 1520.66% from -$613.7 million recorded in Q2 2025.
- In the past 5 years, Dynavax Technologies' Enterprise Value ranged from a high of -$232.7 million in Q1 2021 and a low of -$764.0 million during Q3 2024
- Its 5-year average for Enterprise Value is -$601.4 million, with a median of -$647.8 million in 2025.
- In the last 5 years, Dynavax Technologies' Enterprise Value crashed by 23080.66% in 2021 and then surged by 1656.89% in 2025.
- Quarter analysis of 5 years shows Dynavax Technologies' Enterprise Value stood at -$545.9 million in 2021, then fell by 14.37% to -$624.4 million in 2022, then decreased by 18.88% to -$742.3 million in 2023, then rose by 3.84% to -$713.8 million in 2024, then rose by 9.25% to -$647.8 million in 2025.
- Its last three reported values are -$647.8 million in Q3 2025, -$613.7 million for Q2 2025, and -$661.3 million during Q1 2025.